Advanced Search (Items only)
Tags: 15 patients had stable disease, 2 (n=3), 2 (n=9), 2005, 22 (n=1 patient), 3 (n=1), 4 (n=2(TRUNCATED), 4 (n=6), 7 (n=1 patient), 7 were not evaluable for response because of concurrent radiotherapy, Adolescent Adult Antineoplastic Agents, although they did not have progressive disease (PD) after receiving 1 (n=10), and 1 patient had a major response. Twenty-one patients had PD after 1 (n=3, and myelosuppressive effects were readily managed. Hospitalizations were limited to three patients with bacteremia. Twenty-three patients had a change in therapy, Backlog, Cancer, Cheung NK, diarrheal, Intravenous Male Nervous System Neoplasms/drug therapy Neuroblastoma/drug therapyPalliative Care Quality of Life Research Support, Journal Article, Kramer K, Kushner BH, Modak S, Non-U.S. Gov't Research Support, or 24 (n=1) courses. The most common reasons for changing treatment were to intensify retrieval therapy or to pursue immunotherapy. Of those 23 patients, P.H.S. Retrospective Studies Treatment Outcome, PedPal Lit, Phytogenic/administration & dosage/adverse effects Camptothecin/administration & dosage/adverse effects/analogs & derivatives Child Child, Preschool Female Humans Infusions, U.S. Gov't
atom, dcmes-xml, json, omeka-xml, rss2